FTSE 100 slips on Russia-Ukraine escalation

The FTSE 100 dipped on Tuesday as tensions in Eastern Europe ratcheted up amid threats of a nuclear response by Russia after Ukraine fired missiles at targets in Russia for the first time.

The Ukraine-Russia conflict is a primary uncertainty following the reelection of Donald Trump. However, it’s the outgoing President Biden who sparked the most recent wave of anxiety after giving Ukraine permission to fire long-range missiles into Russia, which it did without delay. 

Russia quickly responded with threats of a nuclear war should attacks supported by foreign-made weapons continue.

The latest escalation follows reports of North Korean troops joining Russian forces to replenish the 10,000s of casualties suffered by the aggressors. Trump has a job on his hands to end the war in 24 hours when he takes control in 2025. 

Uncertainty about Donald Trump’s actions when he enters the White House and worries about interest rates have been unsettling equity investors. The introduction of threats of nuclear missile strikes accelerated the selling of European and US equities, sending major indices sharply lower.

The FTSE 100 reversed early gains in a violent sell-off as news broke about Ukraine striking targets deep inside Russia, leaving London’s leading index trading down 0.36% at the time of writing.

Imperial Brands

Imperial Brands was the top riser after the tobacco company announced final results that showed robust sales across all categories.

“Imperial Brands’ shares have been soaring in 2024, climbing by more than a third, and today brought more good news for shareholders. The tobacco giant reported a 4.6% increase in operating profit for the year, alongside a promise of further shareholder returns through buybacks and dividends,” said Mark Crouch, Market Analyst at eToro.

“Despite a cloud of regulatory uncertainty gathering over the tobacco industry, tobacco stocks continue to attract a long line of investors, even as global demand for traditional tobacco products declines. Imperial Brands’ pivot into vaping products has been a key growth driver as it ramps up investments to diversify its portfolio, positioning itself for potential regulatory headwinds down the road.”

Imperial Brands were 2.7% higher at the time of writing.

At the other end of the leaderboard, Diploma shares sank 7% after missing analyst estimates.

“Industrial-to-healthcare distributor Diploma was the top faller on the FTSE 100 after a rare profit and revenue miss with its full-year results,” said Russ Mould, investment director at AJ Bell.

“The company has built a reputation of being a ‘Steady Eddie’ operator and while the latest figures still show earnings progression, it’s not quite to the level forecast by analysts.”

AIM movers: LungLife AI progress and Enwell Energy licences suspended

2

Lung cancer diagnostic technology developer LungLife AI Inc (LON: LLAI) says that there has been a positive response to the Early Access Programme for LungLB. Orders have been received. Medicare coverage will be applied for. The MoIDx programme has been used to streamline the evaluation process and has provided guidance. Management is still trying to identify the partner it requires to commercialise the product. There was $1.77m in the bank at the end of October and this should last until the second quarter of 2025. The share price recovered 21.2% to 10p.

More good news from ValiRx (LON: VAL). Its subsidiary Inaphaea BioLabs has gained a further contract with Amply Discovery. This will evaluate formulations of Amply’s developmental siRNA targets in Inaphaea’s Triple Negative Breast Cancer (TNBC) Patient Derived Cells (PDCs) both on their own and in combination with other drugs. There is an upfront payment of £31,000 with a further £21,000 after the first phase. The contract could potentially be worth more than £100,000 over an eight-month period. On Monday, the subsidiary confirmed shipment of the first batch of Patient Derived Cells, which are part of a new range of assay ready reagents. The share price rose 16.1% to 1.8p.

Modular housing supplier Eco Buildings Group (LON: ECOB) has received a letter of intent for the purchase of 10,000 modular homes by a company in the Dominican Republic. Subject to regulatory approvals these would be supplied over five years. The contract would be worth $237m. There could potentially be a manufacturing facility set up in the Dominican Republic. The share price increased 14.8% to 7.75p.

Skin health technology developer SkinBioTherapeutics (LON: SBTX) has finalised the commercial agreement with Croda Beauty Care. The deal covers the active cosmetic sector. Croda is paying tiered royalties based on global sales revenues. Croda is not releasing any forecasts of sales. This agreement will help SkinBioTherapeutics to become cash flow positive in the year to June 2025. The share price improved 7.02% to 15.25p.

FALLERS

Woodbois (LON: WBI) is raising £1m at 0.21p/share via Axis Capital Markets. The cash will be used for working capital. The timber company recently raised £484,00 at 0.28p/share. The share price slipped 25.4% to 0.22p.

UK Oil & Gas (LON: UKOG) is raising £500,000 via a placing at 0.025p/share and more could be raised via a retail offer. The cash will be used to purchase a salt cavern hydrogen storage site in the East Yorkshire salt basin. It is near to the planned Project Union hydrogen pipeline network. Relevant IP will also be acquired. Management is talking to an investor for this project and the Dorset project. The retail offer to existing shareholders closes at 5pm on 21 November. The share price declined by one-quarter to 0.0255p.

Enwell Energy (LON: ENW) shares continue to fall following yesterday’s announcement that the licences on the company’s producing oil and gas wells in Ukraine have been suspended because of its ownership structure. This means that Enwell Energy will have no production. It will still be profitable this year but will lose money in 2025. Net cash is expected to be $88.6m at the end of 2024. The share price dipped a further 16.1% to 14.125p.

Yesterday, Caledonian Trust (LON: CNN) shareholders passed the resolution to leave AIM. The last day of trading is 25 November. The share price fell 14.3% to 60p.

Why increased farm inheritance tax will be good for the UK economy

Although the farmers lining up their tractors on Whitehall today may disagree, changing the IHT tax regime around farms may be good for the UK economy.

In 2022/23, the UK farming industry received £2.3bn in government handouts to support activities that would otherwise be uneconomical.

Not many other industries receive such a high level of support to fund business activities that can’t generate returns over the long term. In many respects, the UK taxpayer is propping up an industry that is occupying land that could be better used to help tackle the housing shortage, boost energy security, or facilitate high-end manufacturing.

The UK government has steadfastly supported its budget plans for farm estates over £1 million (£2 million for a couple) to pay 20% inheritance tax and shown no sign of backing down, despite nationwide protests over the weekend and today.

There is a weight of economic evidence that supports the government’s argument that the farming IHT relief schemes have artificially pushed up land prices and degraded soil as farmers overworked the land to meet the demands of high land prices.

In a letter published in the Financial Times, Paul Cheshire, emeritus professor of Economic Geography at the London School of Economics, explained how the introduction of farm IHT relief pushed up the price of farmland and did little to support farmer’s incomes:

“This is because, like most agricultural subsidies, the value of the relief was capitalised into land values. As tax planners cottoned on to its role as a licence to avoid IHT, they advised their super-rich clients to buy land and take advantage of it. In the 20 years to 2012, the price of farmland increased fourfold.

“This turned landowning farmers into millionaires but — especially since land represents a cost of production — did no good to the incomes of food producers. It created impoverished millionaires who claimed a need for more support. At the same time, because more expensive land had to be squeezed even harder for the last drop of revenue, the environmental damage caused by intensive agriculture was made worse. Taking at least some of this tax loophole away will do no harm to family farmers but will help both public revenues and the environment.

Farmers with large estates and low cash levels will have a decision to make. They can pass on the farm and leave it to their executors and beneficiaries to decide how to meet the new IHT liabilities, or they can start selling off land and other assets now to ensure the cash is available to settle the IHT bill on their death. 

Either way, the likely outcome is that some large family-owned farms worth over £2 million will sell a proportion of their land. 

Farm estates selling off their land to housebuilders or renewable energy providers will reduce the amount of land the government has to pay out subsidies for and provide much-needed land to facilitate the construction of the two things the UK is in desperate need of – new homes and a reliable domestic power supply. 

Some may argue that we need to grow more of our own food and that reducing farmland is a bad idea. However, this school of thought is steeped in nostalgia, and the reality is that a large proportion of our food now comes from overseas. The changes in farming IHT tax are simply accelerating a trend already underway. 

In addition, many current farming practices are unsustainable, and there are questions about just how long they can continue.

If the UK really wants to take control of food security, we must invest in technology such as vertical farming to boost food production efficiency. Several firms are emerging winners from the first wave of innovation in the vertical farming sector and are now supplying the UK’s major supermarkets. Insect farms are springing up to provide high-protein animal feed, and lab-grown meat is no longer science fiction.

We could use the UK manufacturing industry as a guide for UK farming. The Industrial Revolution saw a boom in activity that gathered pace until it became cheaper to produce most goods overseas, leaving the UK as a base for specialist high-end manufacturing. Apply this to traditional farming, and we become producers of premium livestock, seasonal fruit and vegetables, and importers of low-margin produce.

Ultimately, the tax changes around farm IHT are speeding up the process of repurposing some UK farmland for uses that provide a better economic return.

And we stress ‘some’ UK farmland.

Given that only around 33% of farms are thought to be impacted by the tax, the family farming sector isn’t about to implode. Grains will still be grown, and cattle will still be reared in the UK. The British strawberry will not go extinct.

Share Tip: Speedy Hire – The shares of this hire group look to be a good growth recovery stock to purchase ahead of Thursday morning’s interims announcement 

On Thursday of this week, 21st November, I would like to see a positive statement from Speedy Hire (LON:SDY), certainly good enough to rekindle some upward action in the group’s share price. 
Currently, they are trading at around the 29.80p level, while analysts are valuing them at up to 51.7p. 
The Business  
Speedy Hire, which was set up in 1977, today is the UK's leading provider of tools and equipment hire services to a substantial range of customers in the construction, infrastructure, industrial, and support services markets. 
It also deals with local trade and indust...

Imperial Brands shares hit five-year high on next generation product strength

Imperial Brands shares jumped on Tuesday, hitting five-year highs after the tobacco and vaping company announced its final results, revealing strong growth in its new generation products segment.

Cigarette smoking rates are rightly falling across the developed world, which poses a big problem for the major listed manufacturers. However, Imperial Brands has done well to pivot into vaping and other nicotine replacement products that now account for around 8% of revenue and may provide the company a future.

“Imperial Brands’ full-year results showed that cigarettes are continuing to fall out of fashion, with tobacco volumes declining by 4%. But this is a dynamic the group is navigating well, managing to drive revenue and profits in the right direction through a combination of strong pricing and impressive growth in Next Generation Products (NGP) such as vapes and heated tobacco, where sales were up 26.4%,” said Derren Nathan, head of equity research, Hargreaves Lansdown.

“Imperial is by no means the leader in this space, but it is a challenger, and at 8% of the total pie, it’s starting to become more meaningful. But for now, it’s still a loss-making activity.”

Although some may be optimistic about the new products, Imperial Brands’ real attraction is its high shareholder capital returns.

“Our operational delivery coupled with consistently strong cash flow generation has supported enhanced shareholder returns with increases to both our ordinary dividend and share buyback,” said Imperial Brands’ CEO Stefan Bomhard.

“We are on track to deliver five-year capital returns of c. £10bn, representing 67% of our market capitalisation in January 2021 when we launched our strategy.”

The company will return £1.25bn to shareholders through share buybacks in FY25. This is arguably the biggest draw into Imperial Brands.

Imperial Brands’ operating profit was almost flat, but EPS jumped 19% due to buybacks reducing available shares. This trend is set to benefit Imperial Brands shareholders in the years to come.

FTSE 100 dips as Melrose jumps

The FTSE 100 traded in a tight range on Monday with little impetus to move UK stocks in either direction.

London’s leading index traded positively for most of the session, gently undulating between flat and up around 20 points. At the time of writing, the index was 0.1% lower at 8,054.

Directionless trade is a symptom of investor uncertainty around Donald Trump’s second and the ramifications for different asset classes and geographies.

Indeed, even US asset classes are sending mixed messages, with the initial rally in stocks easing back and the bond market appearing to chase its tail.

“The US government bond market does not seem quite sure what to make of the prospect of a second Trump presidency, but the US stock market seems happy and so does the US dollar, using the trade-weighted DXY (or ‘Dixie’) index as a guide,” said AJ Bell investment director Russ Mould. 

The market has also shifted focus back to interest rates after comments from US central bankers last week that shattered hopes of sustained cuts in interest rates.

This can explain the drop in US stocks, which is weighing on the global equity complex and taking some attention away from Donald Trump’s questionable cabinet appointments.

One would expect traders to hang on Fed officials’ every word in upcoming speeches for hints of whether borrowing costs will fall further or plateau.

Melrose

Melrose was the standout performer in an otherwise uninspiring trading session, with a 5% gain following the release of an encouraging trading statement.

“Melrose remains on the right flight path to meeting full-year guidance, which calls for underlying operating profits to rise around 33% to £560mn at the midpoint,” said Aarin Chiekrie, equity analyst, Hargreaves Lansdown.

“In a short trading update, the aerospace business revealed that revenue in its Engines division continued to soar at double-digit rates over the four months ending 31 October. 

“The Structures division, which deals with building the body and wings of planes, took some shine off performance with revenue only edging 1% higher. This side of the business has been held back by the planned exit of non-core work and customer destocking in the period. Production troubles at Airbus and quality issues at Boeing have also dented timelines. There’s not a great deal Melrose can do about this – supply chain issues have been a challenge for the whole industry and the problem’s likely to persist for some time.”

The bull case for UK equities

It’s very easy to be pessimistic about UK stocks. However, the bull case for UK equity is much stronger than many market commentators would have you believe.
The headline earnings multiples of UK equities convey deep value, but the bull case for UK equity runs a lot deeper than average price-to-earnings ratios. Several structural tailwinds are set to support the UK equity space in the years to come.
Indeed, there is a lot to look forward to for UK equity investors. Although the UK bull case is not as obvious as the AI-driven tech rally in the United States, there are many reasons to be positi...

AIM movers: China export controls for tungsten help Guardian Metal Resources and Celadon Pharmaceuticals still waiting for cash

0

Guardian Metal Resources (LON: GMET) believes that the tightening of export controls by China enhances the potential for its tungsten project in Nevada. Drilling at the Pilot Mountain project is progressing well. This will support the pre-feasibility study, and the next batch of results should be available in the next few weeks. The share price jumped 19.2% to 28p.

TruFin (LON: TRU) says revenues and EBITDA are well ahead of expectations. Revenues will jump from £18m to £42m. The 2024 pre-tax loss will fall from £6.6m to £2.5m. Games company Playstack has been the main reason behind the upgrade. Net cash should be £6m at the end of 2024. The share price improved 14.8% to 73.5p.

MediaZest (LON: MDZ) has completed a proof of concept project to supply 50 digital currency boards to UK Post Office branches. The service agreement contract is with First Rate Exchange Services. There is a potential market of 1,500 Post Offices. The share price increased 13.3% to 0.085p.

ValiRx (LON: VAL) says that subsidiary Inaphaea BioLabs has confirmed shipment of the first batch of Patient Derived Cells, which are part of a new range of assay ready reagents. The share price rose 12.7% to 1.55p.

FALLERS

Cannabis-based medicines developer Celadon Pharmaceuticals (LON: CEL) has received a further £200,000 drawdown from the committed credit facility and the lender is committed to providing the remaining £500,000. However, it has to sell an investment to provide the cash. There is still £400,000 outstanding from a share subscription. Celadon Pharmaceuticals has enough cash to get it to January. Talks with another lender continue. The share price slumped 30.4% to 19.5p.

Scientific instruments supplier Judges Scientific (LON: JDG) says order intake has reduced if the large Geotek contract is excluded. China is particularly weak, but other markets are also tough, and orders have been deferred. Zeus has cut its 2024 pre-tax profit forecast by 19% to £25m. Next year’s forecast has also been trimmed. The share price fell 12.8% to 8940p.

Autins Group (LON: AUTG) finance director Kamran Munir has resigned with immediate effect. The acoustic materials company will shortly commence the search for a replacement. The company year end is September. The share price slipped 11.8% to 7.5p.

Semiconductor wafers supplier IQE (LON: IQE) is discussing a potential £15m convertible loan note financing from Lombard Odier, its largest shareholder. The conversion price is 15p. There should be no current need for a share issue. There has been a slower than expected recovery in the main sectors because of weak consumer demand. A strategic review will b undertaken. The business in Taiwan was going to float on the local stockmarket, but IQE may consider an outright sale. The share price dipped 4.21% to 10.23p.

Mike Ashley – Certainly one of life’s ‘triers’ – but will he get it on? 

What is the expression?  
All the world likes a ‘trier’! 
And certainly, that is how I consider Mike Ashley, especially in his recent efforts to gain more retail sector dominance. 
Don’t get confused with the term ‘chancer’ because, unless you know differently, I do not believe Ashley to be such a person. 
Just like a footballer running around the field making tackles here, there and everywhere but, as yet, to really score – Ashley charges include N Brown, AO World, Currys, Mulberry, THG, ASOS, Hornby and boohoo Group. 
To Fight Or To Back Away 
Whatever he m...

Bevtech Startup Using TikTok to Take on Big Caffeine 

Irish bevtech start-up GoodBrew is successfully bucking the trend in the current slow FMCG investment environment. The maker of functional cold brew drinks has taken an unconventional approach to their current funding round; turning to social media platform TikTok to attract a younger demographic of investors to its Crowdcube campaign available here.  

The Enterprise Ireland High Potential Start-Up has already exceeded 50% of its fundraising target before the round even goes public on Crowdcube. Dee Schroeder, CEO of GoodBrew, says their target consumer is aged between 18 and 25, so using Gen Z’s favourite platform as a focal point of their fundraising campaign made sense. Their video seeking investment has garnered over 140,000 views to date.  

@lovegoodbrew ✨Here’s your chance to join the GoodBrew crew! ​​✨ 📈 Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong.Take 2 mins to learn more: https://www.crowdcube.com/explore/risk-warning ✅ #irish #UK #fundraising #startup #coffee #business #investment ♬ original sound – lovegoodbrew

“Gen Z makes up about 20% of the population. They’re really smart and have disposable income but are largely ignored by traditional investment platforms so we meet them where they are; online. While we also have more traditional, big-ticket investors on board, it’s really important to us as a brand to build a strong community and stay connected to the people who buy our drinks. Reaching investors via TikTok is the perfect way for GoodBrew fans to own a piece of the action,” says Schroeder.  

GoodBrew makes flavoured cold brew coffee drinks fortified with its GoodGut(™) formula, which contains essential vitamins and gut-friendly fibre. The business has big ambitions to disrupt the £20b RTD cold caffeine market currently dominated by a few large players including Starbucks and Coca-Cola owned Costa.  

The business has rolled out an impressive number of listings with large retailers across Ireland this year, including Tesco, Centra, SuperValu and Dunnes Stores and revenue was up 250% year-over-year in the first half of 2024. The brand just made its first inroads into the UK market via a successful launch on Amazon UK. Industry stakeholders have taken notice of the scrappy newcomer too. GoodBrew has won two Great Taste awards, Best Functional Drink at the World Coffee Innovation Awards and is nominated in four categories in the upcoming World Beverage Innovation Awards.  

GoodBrew’s founders have largely bootstrapped the business to date with support from Enterprise Ireland and founding investor Frank Gleeson, former head of Aramark Europe.   

“I’m thrilled to be part of an exciting journey for Goodbrew. Founders Jeff and Dee have developed an amazing new range of coffee based products. I’m so impressed with their entrepreneurial spirit and drive to give customers a healthy cold coffee alternative which is exactly on trend with consumers,” says Gleeson.  

GoodBrew’s founders say now is the right time for the business to raise to fuel accelerated growth. GoodBrew is using crowdfunding platform Crowdcube to host the public phase of its funding campaign. Those interested can sign up for access here.